PTX 4.44% 4.7¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-288

  1. 127 Posts.
    lightbulb Created with Sketch. 72
    Thanks, this made me go have a look at competitor pipelines. I was a bit sceptical about PTX 100 being a large driver of growth, but after looking at the broad scope that is being applied when just targeting KRASG12C + G12D, I reckon I was pretty wrong especially if it plays well with other therapies.

    Found this Miranti presentation interesting for context
    https://s27.q4cdn.com/140416303/files/doc_presentation/2021/09/Mirati_Corporate-Presentation_20September2021_FINAL_PDF.pptx.pdf



 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
0.002(4.44%)
Mkt cap ! $37.85M
Open High Low Value Volume
4.7¢ 4.7¢ 4.7¢ $8.08K 172.0K

Buyers (Bids)

No. Vol. Price($)
3 2719 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 143045 3
View Market Depth
Last trade - 14.32pm 09/09/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.